A Study of BGM0504 in Chinese Patients With Type 2 Diabetes

Clinical trial NCT06974825 · COMPLETED

Trial details

NCT number: NCT06974825
Sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2023-08-30
Primary completion: 2024-08-13
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.